藥明生物(開曼)有限公司 - 收益表 (TTM)

藥明生物(開曼)有限公司
MX ˙ BMV ˙ KYG970081173
收益表 (TTM)

藥明生物(開曼)有限公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
收入 8,075 9,183 10,290 11,690 13,090 14,179 15,269 15,911 16,554 16,794 17,034 17,075 17,116 17,896 18,675 19,365 20,054 20,922 21,790
改變 (%) 13.72 12.06 13.60 11.97 8.32 7.68 4.21 4.04 1.45 1.43 0.24 0.24 4.55 4.36 3.69 3.56 4.33 4.15
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 4,028 4,744 5,461 6,303 7,144 7,845 8,545 9,114 9,683 9,945 10,206 10,353 10,499 10,762 11,025 11,263 11,501 11,636 11,772
改變 (%) 17.80 15.11 15.41 13.35 9.80 8.92 6.66 6.24 2.70 2.63 1.43 1.41 2.50 2.44 2.16 2.11 1.18 1.16
佔收入的百分比 49.88 51.67 53.07 53.92 54.58 55.32 55.96 57.28 58.49 59.21 59.92 60.63 61.34 60.14 59.03 58.16 57.35 55.62 54.02
營業毛利 4,047 4,438 4,829 5,387 5,945 6,335 6,724 6,798 6,871 6,850 6,828 6,723 6,617 7,134 7,651 8,102 8,554 9,286 10,019
改變 (%) 9.65 8.80 11.56 10.36 6.55 6.15 1.10 1.08 -0.32 -0.32 -1.54 -1.57 7.81 7.24 5.90 5.57 8.56 7.89
佔收入的百分比 50.12 48.33 46.93 46.08 45.42 44.68 44.04 42.72 41.51 40.79 40.08 39.37 38.66 39.86 40.97 41.84 42.65 44.38 45.98
銷售、一般及行政費用 952 1,043 1,133 1,192 1,251 1,472 1,693 1,824 1,956 2,021 2,086 2,221 2,356 2,328 2,299 2,298 2,298 2,408 2,519
改變 (%) 9.48 8.66 5.21 4.95 17.65 15.00 7.80 7.23 3.31 3.20 6.48 6.09 -1.22 -1.23 -0.02 -0.02 4.81 4.59
佔收入的百分比 11.79 11.35 11.01 10.20 9.56 10.38 11.08 11.47 11.82 12.03 12.25 13.01 13.77 13.01 12.31 11.87 11.46 11.51 11.56
研發 295 398 502 579 657 670 683 718 753 769 786 787 788 777 766 766 766 810 853
改變 (%) 35.10 25.98 15.53 13.44 1.94 1.90 5.15 4.90 2.17 2.12 0.17 0.17 -1.40 -1.41 -0.04 -0.04 5.71 5.40
佔收入的百分比 3.65 4.34 4.87 4.96 5.02 4.73 4.47 4.51 4.55 4.58 4.61 4.61 4.61 4.34 4.10 3.96 3.82 3.87 3.92
營運支出 5,287 6,203 7,120 8,098 9,076 9,997 10,918 11,652 12,386 12,744 13,102 13,384 13,666 13,878 14,090 14,327 14,564 14,854 15,144
改變 (%) 17.34 14.77 13.74 12.08 10.15 9.22 6.72 6.30 2.89 2.81 2.16 2.11 1.55 1.53 1.68 1.66 1.99 1.95
佔收入的百分比 65.47 67.56 69.19 69.27 69.34 70.51 71.51 73.23 74.82 75.88 76.91 78.38 79.84 77.55 75.45 73.99 72.62 71.00 69.50
營業收入 2,788 2,979 3,170 3,592 4,014 4,182 4,350 4,259 4,169 4,051 3,933 3,691 3,450 4,018 4,585 5,038 5,490 6,068 6,646
改變 (%) 6.85 6.41 13.31 11.74 4.19 4.02 -2.09 -2.13 -2.83 -2.91 -6.14 -6.54 16.46 14.13 9.86 8.98 10.53 9.53
佔收入的百分比 34.53 32.44 30.81 30.73 30.66 29.49 28.49 26.77 25.18 24.12 23.09 21.62 20.16 22.45 24.55 26.02 27.38 29.00 30.50
利息花費 -41 -40 -39 -40 -41 -53 -64 -92 -121 -140 -158 -153 -148 -153 -158 -165 -173 -158 -143
改變 (%) -2.44 -2.50 2.28 2.23 28.56 22.21 43.61 30.37 15.74 13.60 -3.39 -3.51 3.33 3.22 4.91 4.68 -8.67 -9.49
佔收入的百分比 -0.51 -0.44 -0.38 -0.34 -0.31 -0.37 -0.42 -0.58 -0.73 -0.83 -0.93 -0.90 -0.86 -0.85 -0.84 -0.85 -0.86 -0.76 -0.66
淨利 2,795 3,092 3,388 3,735 4,081 4,251 4,420 4,286 4,152 3,776 3,400 3,016 2,632 2,994 3,356 3,776 4,196 4,552 4,908
改變 (%) 10.62 9.60 10.22 9.28 4.15 3.99 -3.04 -3.13 -9.06 -9.96 -11.29 -12.73 13.75 12.09 12.52 11.12 8.48 7.82
佔收入的百分比 34.61 33.67 32.93 31.95 31.18 29.98 28.95 26.94 25.08 22.48 19.96 17.66 15.38 16.73 17.97 19.50 20.92 21.76 22.53

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:1FW2 €3.75
HK:2269 HK$35.14
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista